Additional Abstracts of Interest in Multiple Myeloma at ASH 2015 | Research To Practice
Amgen's Phase III ASPIRE trial of myeloma treatment Kyprolis meets primary endpoint - Clinical Trials Arena
ASPIRE Trial - KRd VS Rd - Multiple Myeloma Clinical Trials
Emerging immunotherapies in multiple myeloma | The BMJ
Clinical Trials in R/R Multiple Myeloma
The Changing Face of Multiple Myeloma | GoToPER.com
Healthcare reality of the treatment of the high-risk multiple myeloma in Spain | Medicina Clínica (English Edition)
Baseline Characteristics of Patients With Multiple Myeloma According to... | Download Table
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial - The Lancet Oncology
Multiple myeloma treatment and management in the elderly. | Semantic Scholar
Survival and treatment patterns of patients with relapsed or refractory multiple myeloma in France — a cohort study using the French National Healthcare database (SNDS) | Annals of Hematology
Efficacy and safety of carfilzomib for the treatment of multiple myeloma: An overview of systematic reviews - ScienceDirect
Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group - The Lancet Oncology
Carfilzomib in multiple myeloma | PPT
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group - The Lancet Oncology
Multiple myeloma | Nature Reviews Disease Primers
Cancers | Free Full-Text | Genome Instability in Multiple Myeloma: Facts and Factors
Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma | NEJM
Phase 3 Head-to-Head ENDEAVOR Study Demonstrates Superiority Of Kyprolis® (carfilzomib) Over Velcade® (bortezomib) In Patients With Relapsed Multiple Myeloma
Carfilzomib in multiple myeloma | PPT
Takeda Oncology on X: "Multiple #myeloma may be the most common, but DYK there are several other forms of myeloma? Take action, learn more https://t.co/aDKofURa4c https://t.co/aFizSxMTn0" / X
Healthcare reality of the treatment of the high-risk multiple myeloma in Spain | Medicina Clínica (English Edition)
Emerging immunotherapies in multiple myeloma | The BMJ
Cardiovascular Complications of Novel Multiple Myeloma Treatments | Circulation
Multiple #Myeloma is a... - Dr. Reddy's Laboratories Ltd. | Facebook
Multiple myeloma, causes, symptoms, diagnosis, newest treatment & prognosis
Kyprolis® Treatment for Patients With Multiple Myeloma - CancerConnect
